The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions

d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype

(2010) Laura Montefusco et al.   CLINICAL ENDOCRINOLOGY

Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy

(2010) Claudia Giavoli et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

d3-GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adults

(2009) V. J. Moyes et al.   CLINICAL ENDOCRINOLOGY

The common exon 3 polymorphism of the growth hormone receptor gene and the effect of growth hormone therapy on growth in Korean patients with Turner syndrome

(2009) Jung Min Ko et al.   CLINICAL ENDOCRINOLOGY

D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly

(2009) Peter Kamenicky et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy

(2009) O R Adetunji et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Influence of Growth Hormone Receptor d3 and Full-Length Isoforms on Biochemical Treatment Outcomes in Acromegaly

(2009) Antonio Bianchi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Impact of the Exon 3-Deleted Growth Hormone (GH) Receptor Polymorphism on Baseline Height and the Growth Response to Recombinant Human GH Therapy in GH-Deficient (GHD) and Non-GHD Children with Short Stature: A Systematic Review and Meta-Analysis

(2009) M. J. E. Wassenaar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Exon-3 Deleted Growth Hormone Receptor Polymorphism Predisposes to Long-Term Complications of Acromegaly

(2009) M. J. E. Wassenaar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly

(2009) Ignacio Bernabeu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association of the exon 3 deleted/full-lengthGHRpolymorphism with recombinant growth hormone dose in growth hormone-deficient adults

(2009) Silke Meyer et al.   PHARMACOGENOMICS

Common exon 3 polymorphism of the GH receptor (GHR) gene and effect of GH therapy on growth in Korean children with idiopathic short stature (ISS)

(2008) Jung Min Ko et al.   CLINICAL ENDOCRINOLOGY

Influence of the d3-Growth Hormone (GH) Receptor Isoform on Short-Term and Long-Term Treatment Response to GH Replacement in GH-Deficient Adults

(2008) Agatha A. van der Klaauw et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical and Biochemical Impact of the d3 Growth Hormone Receptor Genotype in Acromegaly

(2008) Moisés Mercado et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Influence of the Exon 3-Deleted/Full-Length Growth Hormone (GH) Receptor Polymorphism on the Response to GH Replacement Therapy in Adults with Severe GH Deficiency

(2008) Edna J. L. Barbosa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Transcriptional Regulation of the Human Growth Hormone Receptor (hGHR) Gene V2 Promoter by Transcriptional Activators and Repressor

(2008) Yuhong Wei et al.   MOLECULAR ENDOCRINOLOGY

Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly

(2008) Antonio Bianchi et al.   Pituitary

Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome

(2007) Gerhard Binder et al.   CLINICAL ENDOCRINOLOGY

Influence of Growth Hormone (GH) Receptor Deletion of Exon 3 and Full-Length Isoforms on GH Response and Final Height in Patients with Severe GH Deficiency

(2007) Barbara Räz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Growth Hormone (GH) Dose, But Not Exon 3-Deleted/Full-Length GH Receptor Polymorphism Genotypes, Influences Growth Response to Two-Year GH Therapy in Short Small-for-Gestational-Age Children

(2007) Antonio Carrascosa et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM